• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Pathwork Diagnostics

edit

Pathwork Diagnostics is based in Redwood City, California. The company develops and delivers innovative molecular diagnostics for oncology. The Pathwork Tissue of Origin Test for frozen tissue was the first to receive FDA clearance for a microarray-based gene expression test that aids in identifying challenging tumors, including poorly differentiated, undifferentiated, and metastic cancer.

Recent Milestones

edit

• 
  Pathwork Diagnostics received $30M in Series C funding. (10/6/10)
  Posted 10/7/10 at 9:23pm via dowjones.com
• 
  Pathwork Diagnostics received $11M in Venture Round funding. (7/6/06)
  Posted 4/23/10 at 3:55am
• 
  Pathwork Diagnostics received $2.5M in Series A funding. (10/1/05)
  Posted 8/31/10 at 11:42pm
• 
  Pathwork Diagnostics added Lee McCracken as President, Chief Executive Officer.
  Posted 11/6/12 at 2:11am
• 
  Pathwork Diagnostics added Sharon Tetlow as Chief Financial Officer.
  Posted 11/6/12 at 2:11am
• 
  Pathwork Diagnostics added Ljubomir J. Buturovic as Vice President and Chief Scientist.
  Posted 11/6/12 at 2:11am

Videos

Screenshots

edit

Above: Pathwork Diagnostics
Uploaded: 4/23/10

Sources

1. Cap Funding Report [edit]
2. Cap Funding Report [edit]
3. Alta Partners Leads $30M Series C For Pathwork Diagnostics (fis.dowjones.com) [edit]